Wednesday, February 10, 2021 11:29:17 AM
Does Leronlimab work for severe covid 19? An anecdotal summary regarding my wife, a 70 y/o female with asthma, type 2 diabetes, and high blood pressure.
My wife was intubated on Dec 17. Once she was taken off Bipap and intubated, her chances for survival dropped to the 33-50% range, and many of those survivors wind up forever on the ventilator in long term care facilities.
She received normal standard of care, including antibiotic and steroids (dexamethasone, methyl prednisone) for pneumonia and Remdisivir.
She got her first dose of Leronlimab on Dec 24, her 8th day of intubation. Second dose a week later on Dec 31.
She spent a total of 43 days on a vent, suffering a lung tear and a second bout with pneumonia from the ventilator and a few infections along the way. In spite of all the setback she managed to wean off the vent for good after 43 days, still requiring supplemental oxygen.
Her oxygen needs have steadily dropped, from 4 litres/minute to .5 litre/minute. Her o2 sats on .5 litre have consistently been 96-100. In fact, her oxygen line came off for 4 hours yesterday and she desatted down to an acceptable 90-91. Not even low enough to set off the monitor alarm.
Along the way I've had 2 doctors tell me flat out she should not be among the living.
Every single doctor who's treated her has told me she would require supplemental oxygen probably forever IF she was fortunate enough to get off the vent. Now it looks as if her oxygen needs will be sporadic at most.
She's rehabbing and since I'm willing to do a ton of work in order to get her home as quickly as possible, will probably be returning home next week.
Leronlimab have much to do with all this? I'm convinced it certainly did.
My wife was intubated on Dec 17. Once she was taken off Bipap and intubated, her chances for survival dropped to the 33-50% range, and many of those survivors wind up forever on the ventilator in long term care facilities.
She received normal standard of care, including antibiotic and steroids (dexamethasone, methyl prednisone) for pneumonia and Remdisivir.
She got her first dose of Leronlimab on Dec 24, her 8th day of intubation. Second dose a week later on Dec 31.
She spent a total of 43 days on a vent, suffering a lung tear and a second bout with pneumonia from the ventilator and a few infections along the way. In spite of all the setback she managed to wean off the vent for good after 43 days, still requiring supplemental oxygen.
Her oxygen needs have steadily dropped, from 4 litres/minute to .5 litre/minute. Her o2 sats on .5 litre have consistently been 96-100. In fact, her oxygen line came off for 4 hours yesterday and she desatted down to an acceptable 90-91. Not even low enough to set off the monitor alarm.
Along the way I've had 2 doctors tell me flat out she should not be among the living.
Every single doctor who's treated her has told me she would require supplemental oxygen probably forever IF she was fortunate enough to get off the vent. Now it looks as if her oxygen needs will be sporadic at most.
She's rehabbing and since I'm willing to do a ton of work in order to get her home as quickly as possible, will probably be returning home next week.
Leronlimab have much to do with all this? I'm convinced it certainly did.
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
